3,564
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

MicroRNA-489-3p aggravates neuronal apoptosis and oxidative stress after cerebral ischemia-reperfusion injury

, &
Pages 14047-14056 | Received 10 Dec 2021, Accepted 30 Mar 2022, Published online: 22 Jun 2022

References

  • Banerjee S, Williamson D, Habib N, et al. Human stem cell therapy in ischaemic stroke: a review. Age Ageing. 2011;40(1):7–13.
  • Chelluboina B, Klopfenstein JD, Gujrati M, et al. Temporal regulation of apoptotic and anti-apoptotic molecules after middle cerebral artery occlusion followed by reperfusion. Mol Neurobiol. 2014;49(1):50–65.
  • Catanese L, Tarsia J, Fisher M. Acute ischemic stroke therapy overview. Circ Res. 2017;120(3):541–558.
  • Kristián T. Metabolic stages, mitochondria and calcium in hypoxic/ischemic brain damage. Cell Calcium. 2004;36:221–233.
  • Sanada S, Komuro I, Kitakaze M. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol. 2011;301(5):H1723–41.
  • Broughton B, Reutens D, Sobey C. Apoptotic mechanisms after cerebral ischemia. Stroke. 2009;40(5):e331–9.
  • Kalogeris T, Baines CP, Krenz M, et al. Cell biology of ischemia/reperfusion injury. International Review of Cell and Molecular Biology. 2012;298:229–317.
  • Chen C, Hsieh C. Effect of acupuncture on oxidative stress induced by cerebral ischemia-reperfusion injury. Antioxidants. 2020;9(3):248.
  • Sun J, Niu L, Gao S, et al. miR-509-5p downregulation is associated with male infertility and acts as a suppressor in testicular germ cell tumor cells through targeting MDM2. Onco Targets Ther. 2019;12:10515–10522.
  • Bartel D. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.
  • Bartel D. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233.
  • Zhou X, Qu Z, Zhu C, et al. Identification of urinary microRNA biomarkers for detection of gentamicin-induced acute kidney injury in rats. regulatory toxicology and pharmacology. RTP. 2016;78:78–84.
  • Wei Q, Liu Y, Liu P, et al. MicroRNA-489 induction by hypoxia-inducible factor-1 protects against ischemic kidney injury. J Am Soc Nephrol. 2016;27(9):2784–2796.
  • Horio Y, Hayashi T, Kuno A, et al. Cellular and molecular effects of sirtuins in health and disease. Clin Sci. 2011;121(5):191–203.
  • Hori Y, Kuno A, Hosoda R, et al. Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress. PloS one. 2013;8(9):e73875.
  • Donmez G, Outeiro T. SIRT1 and SIRT2: emerging targets in neurodegeneration. EMBO Mol Med. 2013;5(3):344–352.
  • Herskovits A, Guarente L. SIRT1 in neurodevelopment and brain senescence. Neuron. 2014;81(3):471–483.
  • Wang F, Chen H-Z, X Lv, Liu D-P, et al. SIRT1 as a novel potential treatment target for vascular aging and age-related vascular diseases. Curr Mol Med. 2013;13(1):155–164.
  • Lu H, Wang B. SIRT1 exerts neuroprotective effects by attenuating cerebral ischemia/reperfusion-induced injury via targeting p53/microRNA-22. Int J Mol Med. 2017;39(1):208–216.
  • He Q, Li Z, Wang Y, et al. Resveratrol alleviates cerebral ischemia/reperfusion injury in rats by inhibiting NLRP3 inflammasome activation through sirt1-dependent autophagy induction. Int Immunopharmacol. 2017;50:208–215.
  • Xian W, Li T, Li L, et al. Maresin 1 attenuates the inflammatory response and mitochondrial damage in mice with cerebral ischemia/reperfusion in a SIRT1-dependent manner. Brain Res. 2019;1711:83–90.
  • Li P, Stetler RA, Leak RK, et al. Oxidative stress and DNA damage after cerebral ischemia: potential therapeutic targets to repair the genome and improve stroke recovery. Neuropharmacology. 2018;134:208–217.
  • Nakka V, Gusain A, Mehta SL, et al. Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities. Mol Neurobiol. 2008;37(1):7–38.
  • Tan X, Zhou C, Liang Y, et al. Circ_0001971 regulates oral squamous cell carcinoma progression and chemosensitivity by targeting miR-194/miR-204 in vitro and in vivo. Eur Rev Med Pharmacol Sci. 2020;24(5):2470–2481.
  • Chen S, Wang M, Yang H, et al. LncRNA TUG1 sponges microRNA-9 to promote neurons apoptosis by up-regulated Bcl2l11 under ischemia. Biochem Biophys Res Commun. 2017;485(1):167–173.
  • Wong C, Crack P. Modulation of neuro-inflammation and vascular response by oxidative stress following cerebral ischemia-reperfusion injury. Curr Med Chem. 2008;15(1):1–14.
  • Ding Y, Du J, Cui F, et al. The protective effect of ligustrazine on rats with cerebral ischemia-reperfusion injury via activating PI3K/Akt pathway. Hum Exp Toxicol. 2019;38(10):1168–1177.
  • Guo W, Liu X, Li J, et al. Prdx1 alleviates cardiomyocyte apoptosis through ROS-activated MAPK pathway during myocardial ischemia/reperfusion injury. Int J Biol Macromol. 2018;112:608–615.
  • Yang B, Zang L, Cui J, et al. Circular RNA TTC3 regulates cerebral ischemia-reperfusion injury and neural stem cells by miR-372-3p/TLR4 axis in cerebral infarction. Stem Cell Res Ther. 2021;12(1):125.
  • Lu Y, Han Y, He J, et al. LncRNA FOXD3-AS1 knockdown protects against cerebral ischemia/reperfusion injury via miR-765/BCL2L13 axis. Biomed Pharmacother. 2020;132:110778.
  • Zhao J, Wang B. MiR-7-5p enhances cerebral ischemia-reperfusion injury by degrading sirt1 mRNA. J Cardiovasc Pharmacol. 2020;76(2):227–236.
  • Peng J, Zhou Y, Deng Z, et al. miR-221 negatively regulates inflammation and insulin sensitivity in white adipose tissue by repression of sirtuin-1 (SIRT1). J Cell Biochem. 2018;119(8):6418–6428.
  • Sun B, Liu H, Nie S. S100B protein in serum is elevated after global cerebral ischemic injury. World J Emerg Med. 2013;4(3):165–168.
  • Zhang H, Chen H, Wang W, et al. Sevoflurane reduces ischemic brain injury in rats with diet and streptozotocin-induced diabetes. J Recept Signal Transduct Res. 2018;38:448–454.
  • Jiang H, Lei J, Zhang Y. Protective effect of topiramate on hypoxic-ischemic brain injury in neonatal rat. Asian Pac J Trop Med. 2014;7(6):496–500.
  • Huang W, Meng F, Cao J, et al. Neuroprotective role of exogenous brain-derived neurotrophic factor in hypoxia-hypoglycemia-induced hippocampal neuron injury via regulating Trkb/MiR134 signaling. J Mol Neurosci. 2017;62(1):35–42.
  • Liu F, Sun X, Zhang Y, et al. Curative effects of GM1 in the treatment of severe ischemic brain injury and its effects on serum TNF-α and NDS. Exp Ther Med. 2018;15(6):4851–4855.
  • Ismael S, Zhao L, Nasoohi S, et al. Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke. Sci Rep. 2018;8(1):5971.